The Latest: FDA posts early positive review of Pfizer data
U.S. health regulators say in their initial review that the vaccine from Pfizer is 95% protective against COVID-19.
U.S. health regulators say in their initial review that the vaccine from Pfizer is 95% protective against COVID-19.